Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, July 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 93 articles: HTML format

Single Articles

1. TEKUS V, Borbely E, Zelena D, Czeh B, et al
   Chronic pain and stress: unravelling the common neuroinflammatory, immune and endocrine mechanisms for novel therapeutic approaches.
   Prog Neuropsychopharmacol Biol Psychiatry. 2026 Jul 3:111821.
   PubMed    
   Abstract available
   
   

2. MARTINI MI, Kuja-Halkola R, Butwicka A, Rietz ED, et al
   Associations between childhood somatic conditions and psychiatric diagnoses in autistic young adults: a retrospective, population-based cohort study in Sweden.
   Lancet Child Adolesc Health. 2026 Jul 3:S2352-4642(26)00124.
   PubMed    
   Abstract available
   
   

3. BARRA F, Giannini EG, Centurioni MG, Gustavino C, et al
   Bowel endometriosis: from pathogenesis to clinical management.
   Lancet Gastroenterol Hepatol. 2026 Jul 3:S2468-1253(26)00117.
   PubMed    
   Abstract available
   
   

4. ZHANG J, Li X, Wang Y, Yu C, et al
   Molecular crosstalk of probiotics in gut health: A chemical perspective on metabolite-mediated pathways.
   Food Chem. 2026;524:150253.
   PubMed    
   Abstract available
   
   

5. BENZAMIN M, Chowdhury MZR, Chakroborty P, Ahmed A, et al
   Occult constipation masking as irritable bowel syndrome with predominant diarrhea in Bangladeshi children.
   World J Gastrointest Pathophysiol. 2026;17:121705.
   PubMed    
   Abstract available
   
   

6. ZHAO J, Li X, Dong JX, Yang JY, et al
   Influence of Emotional Disorders on the Efficacy of Acupuncture in Refractory Diarrhea-Predominant Irritable Bowel Syndrome: A Secondary Analysis of a Randomized Controlled Trial.
   J Integr Complement Med. 2026 Jul 2:27683605261461176.
   PubMed    
   Abstract available
   
   

7. BILLING J, Pfabigan DM, Steinsvik EK, Lied GA, et al
   Associations between childhood behavior and current cognitive and emotional function in adults with irritable bowel syndrome-a cross sectional retrospective study.
   BMC Gastroenterol. 2026 Jul 2. doi: 10.1186/s12876-026-05067.
   PubMed    
   Abstract available
   
   

8. STALLER K, Goodory VC, Khasawneh M, Black CJ, et al
   The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy study.
   Lancet Gastroenterol Hepatol. 2026 Jul 2:S2468-1253(26)00118.
   PubMed    
   Abstract available
   
   

9. DUAN R, Zhang T, Lu S, Zhu L, et al
   Causal relationships between irritable bowel syndrome and brain functional networks: A Mendelian randomization study.
   J Transl Int Med. 2026;14:423-435.
   PubMed    
   Abstract available
   
   

10. PETROV JC, Lacy BE, Cangemi DJ
    Managing the Diagnostic and Therapeutic Challenges of Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2026;22:296-302.
    PubMed    
    Abstract available
    
    

11. THAKUR ER, Scarlata K, Spiegel B, Hass DJ, et al
    Beyond Medication: Integrative and Nutrition Therapies for Disorders of Gut-Brain Interaction.
    Gastroenterol Hepatol (N Y). 2026;22:177-187.
    PubMed    
    Abstract available
    
    

12. ZHAO J, Fan Y, Yang K, Gao H, et al
    Fecal microbiota transplantation: from empirical remedy to precision medicine.
    Front Microbiomes. 2026;5:1863308.
    PubMed    
    Abstract available
    
    

13. WU H, Tian J, Luo W, Liu J, et al
    Oral hydrogel systems in lower gastrointestinal disorders: From disease-based therapy to microbiota-guided design.
    Mater Today Bio. 2026;39:103357.
    PubMed    
    Abstract available
    
    

14. VAUGHN H, Long MD, Barnes EL, Herfarth H, et al
    The efficacy and safety of hyoscyamine, dicyclomine, and desipramine in the treatment of irritable pouch syndrome-a retrospective cohort study.
    Crohns Colitis 360. 2026;8:otag063.
    PubMed    
    Abstract available
    
    

15. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    L-Carnitine Improves Visceral Hypersensitivity and Colonic Hyperpermeability in a Rat Model of Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70389.
    PubMed    
    Abstract available
    
    

16. SOMTAS AE, Capar AG
    A Randomized Controlled Trial Comparing Low-FODMAP and Gluten-Free Diets on Gastrointestinal Symptoms, Nutritional Status, and Quality of Life in Irritable Bowel Syndrome.
    Turk J Gastroenterol. 2026 Jun 25. doi: 10.5152/tjg.2026.26147.
    PubMed    
    Abstract available
    
    

17. BASUMATARY D, Saikia A, Pandey M, Borah JC, et al
    Bioactive compounds of Glycyrrhiza glabra and their functional role in modulating gut inflammation and intestinal homeostasis.
    Inflammopharmacology. 2026 Jun 29. doi: 10.1007/s10787-026-02301.
    PubMed    
    Abstract available
    
    

18. LIN LY, Lin YH, Tu CH, Wu MS, et al
    Microbiota dysbiosis and mucosal hyperinnervation contribute to intestinal hyperalgesia in a mouse model of post-infectious irritable bowel syndrome.
    Am J Physiol Gastrointest Liver Physiol. 2026.
    PubMed    
    Abstract available
    
    

19. GILL SK, Chahal S, Sarkar SS, Yadava T, et al
    Development of a double-pharmacophore workflow for screening subtype-selective M(3) muscarinic acetylcholine receptor antagonists.
    Mol Divers. 2026 Jun 28. doi: 10.1007/s11030-026-11619.
    PubMed    
    Abstract available
    
    

20. SAINI V, Verma A, Kumari S, Chaudhary S, et al
    The gut microbiome axis: how Lactobacillus-fermented soymilk orchestrates health.
    Arch Microbiol. 2026;208:321.
    PubMed    
    Abstract available
    
    

21. PANUFNIK P, Wiecek M, Szwarc P, Szydlarska D, et al
    Effect of microencapsulated sodium butyrate on abdominal symptoms and carbohydrate metabolism in patients with type 2 diabetes: a randomized placebo-controlled trial.
    Sci Rep. 2026;16:17404.
    PubMed    
    Abstract available
    
    

22. AIOLFI A, Bona D, Cammarata F, Elshafei M, et al
    Gastrointestinal Complaints After Fundoplication: Rapid Review and Evidence Mapping.
    Curr Gastroenterol Rep. 2026;28:15.
    PubMed    
    Abstract available
    
    

23. ZHANG J, Zhou Y, Mei X, Yan S, et al
    Molecular mechanisms and therapeutic potential of tryptophan metabolism in gut-brain signaling transduction: a narrative review.
    J Neuroinflammation. 2026;23:131.
    PubMed    
    Abstract available
    
    

24. HEYMANN RE, Rezende MC, Braz AS, Ranzolin A, et al
    Brazilian Society of Rheumatology's fibromyalgia treatment guidelines - part I: monitoring and non-pharmacological management.
    Adv Rheumatol. 2026;66:10.
    PubMed    
    Abstract available
    
    

25. DUAN GB, Wang JW, Sun HH, Chen Y, et al
    Microglia-mediated BLA glutamatergic neuronal hyperactivity in the BLA-ACC pathway contributes to stress-induced visceral hypersensitivity and anxiety in rats.
    Mol Med. 2025;31:343.
    PubMed    
    Abstract available
    
    

26. YANG W, Yang J, Zou Q, Tu H, et al
    Intestinal muscularis in health and disease.
    Commun Biol. 2026;9:926.
    PubMed    
    Abstract available
    
    

27. LINARES M, Saps M
    Evaluating linaclotide for the treatment of irritable bowel syndrome with constipation in children and adolescents.
    Expert Opin Pharmacother. 2026 Jul 9. doi: 10.1080/14656566.2026.2702388.
    PubMed    
    Abstract available
    
    

28. MAZUMDER S, Dubey I, Gupta A, Bhardwaj S, et al
    Caffeic acid attenuates stress-induced colon inflammation and barrier disruption in Sprague-Dawley rats.
    Cytokine. 2026;205:157187.
    PubMed    
    Abstract available
    
    

29. STROIE T, Istratescu D, Diculescu RI, Preda CM, et al
    Evaluation of Health-Related Quality of Life in Patients Treated with Synbiotics: a Prospective Observational Study.
    Maedica (Bucur). 2026;21:458-463.
    PubMed    
    Abstract available
    
    

30. CHUANG YC, Huang YJ, Lai MC, Chen WY, et al
    Sex differences in 5-year incidence and prevalence of physical illnesses following early childhood autism diagnosis.
    JCPP Adv. 2026 Feb 19:e70108. doi: 10.1002/jcv2.70108.
    PubMed    
    Abstract available
    
    

31. SHOUP J, Sadle C, Buckley A, Song ZH, et al
    Oxytocin and RAGE signaling at the intersection of social neurodevelopment and inflammation.
    J Transl Med. 2026 Jul 7. doi: 10.1186/s12967-026-08395.
    PubMed    
    Abstract available
    
    

32. BRITTON TA, Grover M
    Barrier restoration as a therapeutic strategy for disorders of gut-brain interaction.
    Lancet Gastroenterol Hepatol. 2026 Jul 7:S2468-1253(26)00081.
    PubMed    
    Abstract available
    
    

33. ANAAM MS, Alfadly SO, Alqasoumi A, Almunef M, et al
    Community pharmacists' preparedness in irritable bowel syndrome management: A descriptive, community-based study on awareness, perceptions, and clinical support practices in Qassim, Saudi Arabia.
    Medicine (Baltimore). 2026;105:e49312.
    PubMed    
    Abstract available
    
    

34. KATSUMATA R, Storsrud S, Nybacka S, Midenfjord I, et al
    Dietary intake patterns in individuals with irritable bowel syndrome identified using Gaussian mixture modeling: a secondary cross-sectional analysis.
    J Acad Nutr Diet. 2026 Jul 6:156408. doi: 10.1016/j.jand.2026.156408.
    PubMed    
    Abstract available
    
    

35. DAVIS JM, Ogbewekon A, Gordon DM, Kipp ZA, et al
    Microbiome-derived cancer: the catabolism of bilirubin to urobilin in the liver-gut axis and its consequences.
    Gastroenterol Rep (Oxf). 2026;14:goag065.
    PubMed    
    Abstract available
    
    

36. SANTOS R, Navarro C
    A Systematic Review and Meta-Analysis of Randomized Clinical Trials of the Efficacy of Mesalazine in Irritable Bowel Syndrome.
    Cureus. 2026;18:e110300.
    PubMed    
    Abstract available
    
    

37. LOU MW, Zhang YQ, Wang YF, Fang JY, et al
    [Systematic review and meta-analysis of the prevalence of small intestinal bacterial overgrowth in patients with functional gastrointestinal disorders].
    Zhonghua Yi Xue Za Zhi. 2026;106:2622-2632.
    PubMed    
    Abstract available
    
    

38. ZUBAREVA NA, Mingazova EN
    [COMORBIDITY IN THE HEALTH STATUS OF ADOLESCENTS AND YOUNG ADULTS - REPRESENTATIVES OF GENERATION Z WITH FUNCTIONAL GASTROINTESTINAL DISORDERS].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2026;34:400-405.
    PubMed    
    Abstract available
    
    

39. XU X, Dong Y, Hu J, He Z, et al
    Planetary health diet index and risk of irritable bowel syndrome: a prospective cohort study.
    Eur J Nutr. 2026;65:199.
    PubMed    
    Abstract available
    
    

40. NASSER Y, Shin A, Ford AC, Camilleri M, et al
    Pathophysiology of irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026 Jul 16:S2468-1253(26)00148.
    PubMed    
    Abstract available
    
    

41. WRIGHT GP, Gu N, Pham NVS, Jones MK, et al
    Clostridioides difficile Infection-Associated Functional Bowel Disorder: A Three-Year Cohort Study.
    Open Forum Infect Dis. 2026;13:ofag408.
    PubMed    
    Abstract available
    
    

42. DE ALBA JG, Cutrona M, Cices A, Dasilva DR, et al
    Resolution of Long-Standing Irritable Bowel Syndrome Symptoms After Treatment of Psoriasis With Risankizumab.
    J Clin Aesthet Dermatol. 2026;19:54-56.
    PubMed    
    Abstract available
    
    

43. ZHOU D, Bai T, Chen J, Wang D, et al
    Symptom Overlap Stratifies Prokinetic Response in Functional Dyspepsia: A Real-World Multicenter Study of 1297 Chinese Patients.
    JGH Open. 2026;10:e70438.
    PubMed    
    Abstract available
    
    

44. AMINI A, Dekel M, Almeida MN, Atkins M, et al
    Provider-Prescribed Restrictive Diets in Patients With Eating Disorders Presenting for Gastroenterology Care.
    Neurogastroenterol Motil. 2026;38:e70397.
    PubMed    
    Abstract available
    
    

45. LIANG X, Deng Y, Zhao L, Zhou X, et al
    From Dysbiotic Gut to Malodorous Mouth: Targeting Microbial Metabolism for Gastrointestinal type halitosis.
    J Breath Res. 2026 Jul 15. doi: 10.1088/1752-7163.
    PubMed    
    Abstract available
    
    

46. TU C, Yang X, Wang Y, Hu J, et al
    Accelerometer-derived "weekend warrior" and regular physical activity on long-term risk of irritable bowel syndrome and subsequent depression: a large-scale prospective cohort study.
    Front Public Health. 2026;14:1865206.
    PubMed    
    Abstract available
    
    

47. CARAYANNOPOULOS NL, Sadh P, Chisango ZM, Jasti S, et al
    The Impact of Irritable Bowel Syndrome on Spine Surgery Outcomes: A Comprehensive Narrative Review.
    J Clin Med. 2026;15:5192.
    PubMed    
    Abstract available
    
    

48. WATROWSKI R, Kostov S, Schafer SD, Juhasz-Boss I, et al
    Low-FODMAP Diet for Gastrointestinal Symptoms in Endometriosis: A Systematic Review.
    Nutrients. 2026;18:2164.
    PubMed    
    Abstract available
    
    

49. AGGELETOPOULOU I, Pastras P, Tsaroucha AK, Triantos C, et al
    A Patient-Centered Ethical Framework for Irritable Bowel Syndrome Care: Communication, Trust, Nutrition-Sensitive Care, and Self-Management.
    Nutrients. 2026;18:2036.
    PubMed    
    Abstract available
    
    

50. BALTIERREZ-HOYOS R, Velazquez-Enriquez JM, Santos-Alvarez JC, Jimenez-Gomez DN, et al
    Molecular Convergence Between Idiopathic Pulmonary Fibrosis and Its Comorbidities Reveals Interactions Between Pulmonary and Systemic Regulatory Programs.
    Biology (Basel). 2026;15:1044.
    PubMed    
    Abstract available
    
    

51. JI L, Huang Y, Zhang J, Lin J, et al
    Single-cell RNA-seq profiles of colonic intestinal mucosa in IBS-D rats to explore the mechanism of immune barrier regulation in pathogenesis.
    Sci Rep. 2026 Jul 14. doi: 10.1038/s41598-026-62190.
    PubMed    
    Abstract available
    
    

52. KHIAL Y, Lathief S, Aliwi L, Alqashouti S, et al
    Dietary patterns, gut microbiota, and gastrointestinal disorders: mechanistic insights into irritable bowel syndrome and inflammatory bowel disease.
    Rev Environ Health. 2026 Jul 16. doi: 10.1515/reveh-2026-0041.
    PubMed    
    Abstract available
    
    

53. WODARCZYK G, Winte M, Mastellone D, Singh T, et al
    Biotic therapies for irritable bowel syndrome: current interventions.
    Gastroenterol Rep (Oxf). 2026;14:goag062.
    PubMed    
    Abstract available
    
    

54. ALMUTAWIF YA, Eid HMA
    Microbiome-metabolite signaling networks in gastrointestinal disease: systems biology, network rewiring, and precision therapeutics.
    Arch Microbiol. 2026;208:483.
    PubMed    
    Abstract available
    
    

55. AHMED I, Chadha K, Paudel KR
    Irritable Bowel Syndrome: Contemporary Management Approaches, Limitations, and Future Directions.
    Cureus. 2026;18:e110741.
    PubMed    
    Abstract available
    
    

56. ALKHALDI M, Vicente AF, Fansey V, Salins RM, et al
    The Gastro-Circadian Metabolic Axis: A Comprehensive Framework for Chronotherapy in Gastroenterology.
    Cureus. 2026;18:e110724.
    PubMed    
    Abstract available
    
    

57. HISENI P, Furu K, Wang Pedersen V, Overland L, et al
    Towards standardized gut microbiota diagnostics: normobiosis beyond geographical borders.
    Gut Microbes. 2026;18:2701485.
    PubMed    
    Abstract available
    
    

58. NISHIMURA H, Higashiyama M, Mizoguchi A, Wada A, et al
    Protective Effect of Uric Acid on Rat Model of Irritable Bowel Syndrome Requires Brain-Gut Communication Through Vagal Cholinergic Pathways.
    Neurogastroenterol Motil. 2026;38:e70396.
    PubMed    
    Abstract available
    
    

59. REES S, Pearlman R, Paskett ED, Shields PG, et al
    Early and late-onset colorectal cancers: a case-case comparison of risk factors.
    Cancer Causes Control. 2026;37:126.
    PubMed    
    Abstract available
    
    

60. LI H, Wang X, Yin L, Li Y, et al
    Abdominal massage alleviates IBS-D by modulating the gut microbiota and suppressing the LPS/TLR4/NF-kappaB/MLCK pathway.
    Front Microbiol. 2026;17:1730607.
    PubMed    
    Abstract available
    
    

61. GAO HQ, Zhang N, Li GN, Wen L, et al
    Da-Jian-Zhong decoction restores the gut-brain balance in diarrhea-predominant irritable bowel syndrome rats via gut microbiota-bile acid axis.
    J Ethnopharmacol. 2026 Jul 24:122224. doi: 10.1016/j.jep.2026.122224.
    PubMed    
    Abstract available
    
    

62. VIBERT J, Stojanov M, Da Silva T, Baud D, et al
    Microbiome and chronic pelvic pain in women: a mini-review.
    Hum Reprod. 2026 Jul 24:deag110. doi: 10.1093.
    PubMed    
    Abstract available
    
    

63. SCRIVIN R, Daniel NVS, Slater G, Costa RJS, et al
    Dietary FODMAP Manipulation for Exercise-Associated Gastrointestinal Symptoms: Why Symptom Severity Should Guide Our Approach.
    Sports Med. 2026 Jul 24. doi: 10.1007/s40279-026-02474.
    PubMed    
    Abstract available
    
    

64. SHEPHERD JM, Rogers AH, Redmond BY, Garey L, et al
    Exploring the role of chronic overlapping pain conditions on smoking dependence, cessation challenges, and internalizing psychopathology among individuals with irritable bowel syndrome who smoke.
    J Behav Med. 2026 Jul 24. doi: 10.1007/s10865-026-00700.
    PubMed    
    Abstract available
    
    

65. JUSTRIBO-MANION C, Ignacio de Oliveira J, Van De Meer H, Barbosa da Silva J, et al
    Are gastrointestinal, gynecological and urogenital chronic overlapping pain conditions (COPCs) predisposing or perpetuating factors for orofacial pain (OFP)? A systematic review.
    Dent Med Probl. 2026;63:749-770.
    PubMed    
    Abstract available
    
    

66. MUNGALE MM, Thatere AA
    Ayurvedic management of Irritable Bowel Syndrome (Grahani Roga): A case report.
    J Ayurveda Integr Med. 2026;17:101377.
    PubMed    
    Abstract available
    
    

67. MADVA EN, Huffman JC, Burton-Murray H, McGranaghan E, et al
    The WISH 2.0 Intervention for Irritable Bowel Syndrome: Protocol for a Pilot Randomized Controlled Trial.
    JMIR Res Protoc. 2026;15:e98352.
    PubMed    
    Abstract available
    
    

68. ALGHAMDI A, Alsalmi T, Alzahrani S, Alazwari A, et al
    Sulpiride-Induced Severe Hyperprolactinemia in an IBS Patient: A Case Report From Saudi Arabia.
    AACE Endocrinol Diabetes. 2026;13:630-632.
    PubMed    
    Abstract available
    
    

69. PIERCE C, Coetzee O
    Diamine Oxidase Supplementation for Histamine Regulation in Constipation-Predominant Irritable Bowel Syndrome: A Case Report.
    Integr Med (Encinitas). 2026;25:22-26.
    PubMed    
    Abstract available
    
    

70. LIU J, Lv C, Zhu X, Hong N, et al
    Noninvasive electrical neuromodulation involving vagus nerve mechanism for functional constipation and irritable bowel syndrome with constipation.
    Ther Adv Gastroenterol. 2026;19:17562848261469142.
    PubMed    
    Abstract available
    
    

71. WU R, Pan J
    Clinical efficacy and gastrointestinal hormonal effect of Lactobacillus rhamnosus combined with lactulose for treatment of irritable bowel syndrome with constipation.
    Am J Transl Res. 2026;18:5236-5247.
    PubMed    
    Abstract available
    
    

72. FAROOQ U, Sadiqa A, Arshad Jarral S
    Pathophysiological and Therapeutic Association between Brain-Gut Axis and Irritable Bowel Syndrome: A Systematic Review.
    Pak J Med Sci. 2026;42:1869-1876.
    PubMed    
    Abstract available
    
    

73. HUSSEIN SM, Okasha S, Omair N, Bakarshoom F, et al
    Screening for irritable bowel syndrome and its associated factors among patients with type 2 diabetes mellitus attending outpatient clinics in Jeddah, Saudi Arabia: A cross-sectional study.
    J Family Med Prim Care. 2026;15:2113-2122.
    PubMed    
    Abstract available
    
    

74. CHEN CY, Chen X, Wang X, Wang ZY, et al
    [Study on the mechanism of electroacupuncture at "Shangjuxu"(ST37) in regulating the expression of NGF mediated by 5-HT(7) receptor and relieving visceral hypersensitivity in IBS rats].
    Zhen Ci Yan Jiu. 2026;51:877-886.
    PubMed    
    Abstract available
    
    

75. YU C, Yu J, Yao X, Wang K, et al
    Mertk-dependent immune regulation is required for the therapeutic effects of fecal microbiota transplantation in a mouse model of constipation-predominant irritable bowel syndrome.
    Life Sci. 2026;402:124595.
    PubMed    
    Abstract available
    
    

76. BALASAN N, Kharrat F, Lega S, Di Leo G, et al
    Probiotics in pediatric functional abdominal pain disorders: a systematic review and meta-analysis.
    Eur J Pediatr. 2026;185:592.
    PubMed    
    Abstract available
    
    

77. LIANG Y, Hou R, Wu L, Jin Y, et al
    Aberrant Nodal Topological Properties and Functional Connectivity of Amygdala Subregions Underlie Emotion-Visceral Integration Impairment in IBS With Depressive Symptoms.
    Neural Plast. 2026;2026:e7203336.
    PubMed    
    Abstract available
    
    

78. DONICKE J, Cooper R, Soehner A, Jalbrzikowski M, et al
    Risk factors associated with longitudinal trajectories of mania symptoms in youth.
    Dev Psychopathol. 2026 Jul 20:1-12. doi: 10.1017/S0954579426101606.
    PubMed    
    Abstract available
    
    

79. ISMAIEL A, Leucuta DC, Boitos I, Foucambert P, et al
    From Visceral Pain to Emotional Distress: Comparative Effectiveness of Antispasmodics and Antidepressants in Irritable Bowel Syndrome - Systematic Review and Network Meta-analysis.
    J Gastrointestin Liver Dis. 2026 Jul 17. doi: 10.15403/jgld-6815.
    PubMed    
    Abstract available
    
    

80. HAKIMI Y, Giles E
    Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety.
    Aliment Pharmacol Ther. 2026 Jun 29. doi: 10.1111/apt.70830.
    PubMed    
    
    
    

81. CRISTOFORI F, Dargenio VN, Castellaneta SP, Francavilla R, et al
    Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Authors' Reply.
    Aliment Pharmacol Ther. 2026 Jul 20. doi: 10.1111/apt.70866.
    PubMed    
    
    
    

82. CHEY WD, Lembo AJ, Yang Y, Rosenbaum DP, et al
    Correction to Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2).
    Am J Gastroenterol. 2026 Jul 14. doi: 10.14309/ajg.0000000000004082.
    PubMed    
    
    
    

83. LACY BE, Farmer AD, Tornblom H
    Case-based Diagnostic Algorithms and Multidimensional Clinical Profiles for common Disorders of Gut-Brain Interaction using Rome V criteria.
    Am J Gastroenterol. 2026 Jul 21. doi: 10.14309/ajg.0000000000004131.
    PubMed    
    Abstract available
    
    

84. OTAY LULE N, Yurttagul M, Yildirim AE, Lule KO, et al
    Comparative Effects of Four Dietary Approaches on Symptom Severity and Quality of Life in Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Dig Dis Sci. 2026 Jul 20. doi: 10.1007/s10620-026-10126.
    PubMed    
    Abstract available
    
    

85. ZHENG HZ, Zou HL, Chen BH, Li YJ, et al
    Acupuncture versus sham non-acupoint acupuncture for irritable bowel syndrome: a systematic review and meta-analysis.
    Gastroenterology. 2026 Jul 7:S0016-5085(26)07037.
    PubMed    
    Abstract available
    
    

86. JUOZAS K, Ianiro G
    Finding the Signal in the Noise: Can Fecal Microbiota Transplantation Deliver for Irritable Bowel Syndrome?
    Gastroenterology. 2026 Jul 15:S0016-5085(26)07060.
    PubMed    
    
    
    

87. DI LORENZO B, Camargo Tavares L, Diaz-Munoz C, Heredia-Fernandez F, et al
    Cross-definition GWAS of IBS in 2.8 million individuals reveals cardiometabolic and triglyceride-linked mechanisms.
    Gut. 2026 Jul 9:gutjnl-2026-338800. doi: 10.1136/gutjnl-2026-338800.
    PubMed    
    Abstract available
    
    

88. VON MUHLENBROCK C, Vanuytsel T, Tack J
    Should serotonin-noradrenaline reuptake inhibitors be considered the most effective neuromodulators for irritable bowel syndrome?
    Gut. 2026 Jul 22:gutjnl-2026-340002. doi: 10.1136/gutjnl-2026-340002.
    PubMed    
    
    
    

89. SONNENBERG A, Bakis LK, Kohen R
    Gastrointestinal Diagnoses and Symptoms in Medicare Patients With Neuropsychiatric Diseases.
    J Clin Gastroenterol. 2026 Jul 13. doi: 10.1097/MCG.0000000000002422.
    PubMed    
    Abstract available
    
    

90. SANTUCCI NR, Dike CR, Hellmann J, Ollberding NJ, et al
    Gut microbiome in pediatric acute pancreatitis and Crohn's disease versus irritable bowel syndrome and healthy controls.
    J Pediatr Gastroenterol Nutr. 2026 Jul 14. doi: 10.1002/jpn3.70504.
    PubMed    
    Abstract available
    
    

91. SMAKOWSKI A, Lowe B, Pauls F, Hahn S, et al
    Applying the functional somatic disorder classification to somatic symptom disorder: Findings from the SOMA.SSD study.
    J Psychosom Res. 2026;210:112916.
    PubMed    
    Abstract available
    
    

92. MAKOWSKI AC, Barbek R, Huber T, Lowe B, et al
    Intersectional inequalities in somatic symptom severity: A trans-diagnostic MAIHDA analysis of SOMACROSS data.
    J Psychosom Res. 2026;210:112918.
    PubMed    
    Abstract available
    
    

93. ZHANG K, Mou F, Liu J, Wang J, et al
    Dysregulated glucocorticoid-responsive immune genes in peripheral blood mononuclear cells as a shared molecular signature of autism spectrum disorder and irritable bowel syndrome.
    PLoS One. 2026;21:e0353181.
    PubMed    
    Abstract available